The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Recent advances in understanding the mechanism of action of bisphosphonates
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dunford, J. E., Thompson, K., Coxon, F. P., Luckman, S. P., Hahn, F. M., Poulter, C. D., Ebetino, F. H., & Rogers, M. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38786-5 · Cited by 900
Self-citationNancollas, G. H., Tang, R., Phipps, R. J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R. G. G., & Ebetino, F. H. (2006) · Bone · doi:10.1016/j.bone.2005.05.003 · Cited by 862
Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells
Gober, H.-J., Kistowska, M., Angman, L., Jenö, P., Mori, L., & De Libero, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021500 · Cited by 847
Fisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., Wesolowski, G., Russell, R. G. G., Rodan, G. A., & Reszka, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.133 · Cited by 676
Self-citationNew Insights Into the Molecular Mechanisms of Action of Bisphosphonates
Rogers, M. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033453640 · Cited by 579
Self-citationBoissier, S., Ferreras, M., Peyruchaud, O., Magnetto, S., Ebetino, F. H., Colombel, M. C., Delmas, P. D., Delaissé, J., & Clézardin, P. (2000) · PubMed · Cited by 573
Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing Bisphosphonates
van Beek, E., Pieterman, E., Cohen, L., Löwik, C., & Papapoulos, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1499 · Cited by 496
Frith, J. C., Mönkkönen, J., Blackburn, G. M., Russell, R. G. G., & Rogers, M. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1358 · Cited by 437
Self-citationBisphosphonates: Preclinical Review
Green, J. R. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-3 · Cited by 405
Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase
Bergstrom, J. D., Bostedor, R. G., Masarachia, P. J., Reszka, A. A., & Rodan, G. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1502 · Cited by 402
γ/δ T-Cell Stimulation by Pamidronate
Kunzmann, V., Bauer, E., & Wilhelm, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400914 · Cited by 395
Lerner, E. C., Qian, Y., Blaskovich, M. A., Fossum, R. D., Vogt, A., Sun, J., Cox, A. D., Der, C. J., Hamilton, A. D., & Sebti, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26802 · Cited by 361
The acute-phase response after bisphosphonate administration
Adami, S., Bhalla, A. K., Dorizzi, R., Montesanti, F., Rosini, S., Salvagno, G., & Lo Cascio, V. (1987) · Calcified Tissue International · doi:10.1007/bf02556671 · Cited by 357
Lehenkari, P. P., Kellinsalmi, M., Näpänkangas, J. P., Ylitalo, K. V., Mönkkönen, J., Rogers, M. J., Azhayev, A., Väänänen, H. K., & Hassinen, I. E. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12222-5 · Cited by 333
Self-citationMönkkönen, H., Auriola, S., Lehenkari, P., Kellinsalmi, M., Hassinen, I. E., Vepsäläinen, J., & Mönkkönen, J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706628 · Cited by 280
Structural Basis for Bisphosphonate-mediated Inhibition of Isoprenoid Biosynthesis
Hosfield, D. J., Zhang, Y., Dougan, D. R., Broun, A., Tari, L. W., Swanson, R. V., & Finn, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300511200 · Cited by 272
Frith, J. C., M�nkk�nen, J., Auriola, S., M�nkk�nen, H., & Rogers, M. J. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<2201::aid-art374>3.0.co;2-e · Cited by 268
Self-citationComparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones
Masarachia, P., Weinreb, M., Balena, R., & Rodan, G. A. (1996) · Bone · doi:10.1016/8756-3282(96)00182-2 · Cited by 248
Thompson, K., Rogers, M. J., Coxon, F. P., & Crockett, J. C. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020776 · Cited by 242
Self-citationHewitt, R. E., Lissina, A., Green, A. E., Slay, E. S., Price, D. A., & Sewell, A. K. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02665.x · Cited by 241
Mechanisms of Statin-mediated Inhibition of Small G-protein Function
Cordle, A., Koenigsknecht-Talboo, J., Wilkinson, B., Limpert, A., & Landreth, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505268200 · Cited by 235
Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs
Rondeau, J., Bitsch, F., Bourgier, E., Geiser, M., Hemmig, R., Kroemer, M., Lehmann, S., Ramage, P., Rieffel, S., Strauss, A., et al. (2006) · ChemMedChem · doi:10.1002/cmdc.200500059 · Cited by 226
Statins Prevent Bisphosphonate-Induced γ,δ-T-Cell Proliferation and Activation In Vitro
Thompson, K., & Rogers, M. J. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301230 · Cited by 217
Self-citationInhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
Halasy-Nagy, J. M., Rodan, G. A., & Reszka, A. A. (2001) · Bone · doi:10.1016/s8756-3282(01)00615-9 · Cited by 190
Dunford, J. E., Rogers, M. J., Ebetino, F. H., Phipps, R. J., & Coxon, F. P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060118 · Cited by 189
Self-citationDifferentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates
van Beek, E. R., Cohen, L. H., Leroy, I. M., Ebetino, F. H., Löwik, C. W. G. M., & Papapoulos, S. E. (2003) · Bone · doi:10.1016/j.bone.2003.07.007 · Cited by 184
Staal, A., Frith, J. C., French, M. H., Swartz, J., Güngör, T., Harrity, T. W., Tamasi, J., Rogers, M. J., & Feyen, J. H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.88 · Cited by 174
Self-citationCoxon, F. P., Helfrich, M. H., Larijani, B., Muzylak, M., Dunford, J. E., Marshall, D., McKinnon, A. D., Nesbitt, S. A., Horton, M. A., Seabra, M. C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106473200 · Cited by 161
Self-citationVecchione, C., & Brandes, R. P. (2002) · Circulation Research · doi:10.1161/01.res.0000028004.76218.b8 · Cited by 161
Leu, C., Luegmayr, E., Freedman, L. P., Rodan, G. A., & Reszka, A. A. (2005) · Bone · doi:10.1016/j.bone.2005.07.023 · Cited by 154
Martin, M., Arnold, W. D., Heath, H. T., Urbina, J. A., & Oldfield, E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1404 · Cited by 153
Lackner, M. R., Kindt, R. M., Carroll, P. M., Brown, K. A., Cancilla, M. R., Chen, C., de Silva, H., Franke, Y., Guan, B., Heuer, T., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.024 · Cited by 136
Allal, B., Favre, G., Couderc, B. C., Salicio, S., Doisneau-Sixou, S. F., Hamilton, A. D., Sebti, S. M., Lajoie‐Mazenc, I., & Pradines, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005264200 · Cited by 112
Coxon, F. P., Ebetino, F. H., Mules, E. H., Seabra, M. C., McKenna, C. E., & Rogers, M. J. (2005) · Bone · doi:10.1016/j.bone.2005.04.021 · Cited by 98
Self-citationThe Role of Prenylated Small GTP-Binding Proteins in the Regulation of Osteoclast Function
Coxon, F. P., & Rogers, M. J. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2017-2 · Cited by 94
Self-citationAlkylamines cause Vγ9Vδ2 T-cell activation and proliferation by inhibiting the mevalonate pathway
Thompson, K., Rojas-Navea, J., & Rogers, M. J. (2005) · Blood · doi:10.1182/blood-2005-03-1025 · Cited by 89
Self-citationSzabo, C. M., Matsumura, Y., Fukura, S., Martin, M., Sanders, J. M., Sengupta, S., Cieslak, J. A., Loftus, T. C., Lea, C. R., Lee, H.-J., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010412y · Cited by 89
Antagonistic Effects of Different Classes of Bisphosphonates in Osteoclasts and Macrophages In Vitro
Frith, J. C., & Rogers, M. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.204 · Cited by 76
Self-citationSchindeler, A., & Little, D. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.198 · Cited by 63
Roelofs, A. J., Hulley, P. A., Meijer, A., Ebetino, F. H., Russell, R. G. G., & Shipman, C. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21977 · Cited by 62
Involvement of vacuolar H+-ATPase in incorporation of risedronate into osteoclasts
Takami, M., Suda, K., Sahara, T., Itoh, K., Nagai, K., Sasaki, T., Udagawa, N., & Takahashi, N. (2003) · Bone · doi:10.1016/s8756-3282(03)00024-3 · Cited by 34
Cited by
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Physiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,585
Russell, R. G. G., Watts, N. B., Ebetino, F. H., & Rogers, M. J. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0540-8 · Cited by 1,411
Self-citationJabłońska-Trypuć, A., Matejczyk, M., & Rosochacki, S. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1161620 · Cited by 1,042
Molecular Mechanisms of Action of Bisphosphonates: Current Status
Roelofs, A. J., Thompson, K., Gordon, S., & Rogers, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0843 · Cited by 568
Self-citation
Metadata
- Authors
- COXON, F., THOMPSON, K., & ROGERS, M.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 6
- Issue
- 3
- Pages
- 307-312
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2142670098
- Cited by
- 252
- References
- 41
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.